Search All News
Columbia researchers have isolated antibodies from COVID-19 patients that neutralize SARS-CoV-2 virus and could be used to treat patients or prevent infections.
Source:New York Post
Commissioner Adam Silver announced that the NBA will not restart its games although the pandemic is having a huge financial impact on the NBA, there remains too many unknowns to proceed otherwise.
ADARC has taken a leading role in clinical, applied, and basic research related to COVID-19 due to its extensive expertise in COVID-19 virology, clinical treatment, basic research, and drug discovery.
Source:Columbia University Irving Medical Center
COVID-19 tests are being processed each day by the Clinical Microbiology Lab at New York-Presbyterian/CUIMC to detect the presence of the virus in nasopharyngeal samples to determine infection.
Source:The GuardianApril 5, 2020
The UK has invested heavily in newly developed home testing kits to test for antibodies to the SARS-CoV-2 virus. At issue is the sensitivity of the test and the levels of antibodies in the population.
Source:China DailyApril 4, 2020
Public health experts from China, Japan, Singapore, South Korea, and the U.S. discussed experiences and lessons learned from the front-line responses to COVID-19.
Source:NBC NewsMarch 20, 2020
New York city is not only the U.S. epicenter of the SARS-CoV-2 pandemic, but it is also on the cutting edge research into understanding and identifying strategies to treat and prevent the infection.
Source:Bloomberg BusinessweekMarch 20, 2020
Dr. Ho is leading four research teams at Columbia University to identify antivirals as well as monoclonal neutralizing antibodies that may be used to treat and prevent infection with SARS-CoV-2.
Source:CaltechMarch 20, 2020
Dr. David Ho had a Q&A with members of the Caltech community to discuss the novel coronavirus and the future of our society in the light of this global pandemic.
Source:PBSMarch 19, 2020
Dr. David Ho is a world-renowned doctor and researcher on the frontlines of the current crisis. He joins Walter Isaacson to explain the lessons we should have learned from the 2003 SARS outbreak.